1-3 of 3
Annelien Van Dalem
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis

Free
Aster K. Desouter, Bart Keymeulen, Ursule Van de Velde, Annelien Van Dalem, Bruno Lapauw, Christophe De Block, Pieter Gillard, Nicole Seret, Eric V. Balti, Elena R. Van Vooren, Willem Staels, Sara Van Aken, Marieke den Brinker, Sylvia Depoorter, Joke Marlier, Hasan Kahya, Frans K. Gorus
Journal: Diabetes Care
Diabetes Care 2025;48(4):528–536
https://doi.org/10.2337/dc24-2376
Published: 04 February 2025
View articletitled, Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis
Open the PDF for Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis in another window
Journal Articles

Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes

Free
Frans K. Gorus, Eric V. Balti, Anissa Messaaoui, Simke Demeester, Annelien Van Dalem, Olivier Costa, Harry Dorchy, Chantal Mathieu, Luc Van Gaal, Bart Keymeulen, Daniël G. Pipeleers, Ilse Weets, for the Belgian Diabetes Registry
Journal: Diabetes Care
Diabetes Care 2017;40(8):1065–1072
https://doi.org/10.2337/dc16-2228
Published: 11 July 2017
View articletitled, Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes
Open the PDF for Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes

Free
Simke Demeester, Bart Keymeulen, Leonard Kaufman, Annelien Van Dalem, Eric V. Balti, Ursule Van de Velde, Patrick Goubert, Katrijn Verhaeghen, Howard W. Davidson, Janet M. Wenzlau, Ilse Weets, Daniel G. Pipeleers, Frans K. Gorus
Journal: Diabetes Care
Diabetes Care 2015;38(4):644–651
https://doi.org/10.2337/dc14-1575
Published: 12 January 2015
View articletitled, Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
Open the PDF for Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes in another window
Includes: Supplementary data